# A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)

> **NCT00351533** · PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 90 (actual)

## Conditions studied

- Respiratory Distress Syndrome, Adult
- Acute Lung Injury
- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Fish oil (eicosapentaenoic acid and docosahexanoic acid)

## Key facts

- **NCT ID:** NCT00351533
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2009-01
- **Final completion:** 2009-08
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2011-10-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351533, "A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00351533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*